Standard BioTools Inc. (LAB) earnings
LAB earnings moved a median of -0.21% by the close. Quarterly and annual LAB reports and results, each read against the price at its own news timestamp. Back to the LAB overview →
30 measured LAB earnings events.
Where these LAB earnings landedvs 28 measured LAB earnings reactions
| Middle 50% of LAB earnings reactions | -3.41% to +4.24% |
|---|---|
| Median reaction (to close) | -0.21% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 LAB earnings events with a measured close landed between -3.41% and +4.24%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q STANDARD BIOTOOLS INC. For: Sep 30 | SEC filing · Form 10-Q | +1.07% | +1.77% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Jun 30 | SEC filing · Form 10-Q | +2.42% | +4.26% | |
| Standard BioTools Reports Second Quarter 2026 Financial Results | Press release | +2.42% | +4.26% | |
| Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026 | Press release | -0.26% | -7.00% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Mar 31 | SEC filing · Form 10-Q | +3.02% | +4.72% | |
| Standard BioTools Reports First Quarter 2026 Financial Results | Press release | -4.98% | -3.15% | |
| Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 | Press release | -0.32% | -1.66% | |
| Form 10-K STANDARD BIOTOOLS INC. For: Dec 31 | SEC filing · Form 10-K | +1.56% | +3.34% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Sep 30 | SEC filing · Form 10-Q | -1.68% | -4.20% | |
| Standard BioTools Reports Third Quarter 2025 Financial Results | Press release | -1.68% | -4.20% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Jun 30 | SEC filing · Form 10-Q | +0.39% | -2.31% | |
| Form NT 10-Q STANDARD BIOTOOLS INC. For: Aug 11 | SEC filing · Form NT | +0.00% | — | |
| Standard BioTools Reports Second Quarter 2025 Financial Results | Press release | +0.80% | — | |
| Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025 | Press release | +0.41% | +2.44% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -9.73% | |
| Standard BioTools Reports First Quarter 2025 Financial Results | Press release | +0.00% | -9.73% | |
| Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025 | Press release | +0.83% | +4.96% | |
| Form 10-K STANDARD BIOTOOLS INC. For: Dec 31 | SEC filing · Form 10-K | -1.83% | +4.59% | |
| Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025 | Press release | +0.01% | +4.23% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Sep 30 | SEC filing · Form 10-Q | +0.44% | -3.11% | |
| Standard BioTools Reports Third Quarter 2024 Financial Results | Press release | +5.46% | -1.01% | |
| Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024 | Press release | -0.52% | -1.56% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Jun 30 | SEC filing · Form 10-Q | -7.60% | -7.60% | |
| Standard BioTools Reports Second Quarter 2024 Financial Results | Press release | -16.43% | -11.25% | |
| Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024 | Press release | +0.00% | +2.20% | |
| Form 10-Q STANDARD BIOTOOLS INC. For: Mar 31 | SEC filing · Form 10-Q | -0.21% | +0.00% | |
| Standard BioTools Reports First Quarter 2024 Financial Results | Press release | +6.25% | +7.59% | |
| Form 10-K/A STANDARD BIOTOOLS INC. For: Dec 31 | SEC filing · Form 10-K | +2.24% | +0.81% | |
| Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 | Press release | -5.06% | -0.42% | |
| Form 10-K STANDARD BIOTOOLS INC. For: Dec 31 | SEC filing · Form 10-K | +1.01% | +4.45% |
Keep exploring
More LAB: analyst actions → · SEC filings → · LAB overview →